Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Marathon Petroleum heads into its October 27 earnings date with a remarkable disconnect: the stock is up 12% on the week and 14% over the past month, yet the analyst consensus price target is still playing catch-up after years of lagging the rally.
The Street angle is the most compelling tension this week. Targets have been moving fast, but consensus has struggled to keep pace with the stock's run. Mizuho's Nitin Kumar raised his target to $457 this morning from $304, a 50% lift while keeping a Neutral rating. That follows Goldman Sachs raising to $472 last month and Morgan Stanley to $453 from $265. The direction of travel is unmistakably upward, with most firms maintaining positive ratings and lifting numbers aggressively. The lone dissenter in the recent run was Jefferies, which downgraded to Hold in late September. The mean target across the consensus now sits around $386, well below the current $442 close, suggesting that despite the flurry of raises, the Street as a whole has not yet declared the re-rating complete. Bulls point to best-in-class capital allocation, refining capture above 100% year-to-date, and MPLX distributions that effectively cover parent-level capex and dividends, freeing cash for buybacks. Bears flag cyclicality risk, tighter crack spreads, and a Q1 that was by one measure the weakest in a decade due to unplanned downtime and heavy turnaround activity.
Valuation multiples reflect the move. The trailing PE has compressed to around 8.4x over 30 days, down nearly 1.8 turns as earnings held firm while the price ran. EV/EBITDA has similarly eased, now at 6.5x, about half a turn below where it traded a month ago. Factor scores reinforce the momentum story: EPS momentum ranks in the 95th percentile on both the 30-day and 90-day windows. The dividend score is also strong at the 92nd percentile, though dividend history data in the feed is dated and not worth quoting directly. The forward EPS growth score is weak at the 34th percentile, which aligns with the bear case that peak-cycle earnings may already be in the numbers.
Short positioning offers almost no resistance to the move. At 1.8% of free float, short interest is low by any measure, and it has halved over the past month, falling from around 9 million shares in mid-September to just over 5 million now. Borrowing costs are negligible at 0.35%, down 25% on the week. Availability is extraordinarily loose at over 3,000%, meaning the lending pool holds roughly 30 times as many shares available to borrow as are currently shorted. There is no mechanical squeeze dynamic here. The ORTEX short score of 31.4 sits well within a stable, low range and has barely moved in two weeks. Options positioning is mildly defensive, with the put/call ratio at 1.13, close to its 20-day average of 1.11 and near the top of the year's range at 1.21, but the z-score of 0.21 signals nothing unusual. The refining sector broadly has been strong: close peer VLO gained 9.4% on the week and PSX added 6.4%, though MPC's 11.8% weekly gain leads the group. CVI was the only name that came close, up 12.5%.
One data point worth flagging from the alt data layer: Wikipedia page views for Marathon Petroleum are running at a z-score of 2.4 against the company's own 90-day history, as of late September. The Wikimedia Foundation data tracks retail attention, not a revenue signal, but the spike suggests the stock's run has attracted a noticeably wider audience than usual. The alt data layer has no measured leading indicator datasets for MPC, so nothing here speaks to what the Q3 print will show.
On the insider side, the recent SEC EDGAR record is modest and largely reflects compensation mechanics. The largest discrete trades in the 90-day window were a cluster of option exercises and same-day sales by the Chief Legal Officer in August, conducted under a pre-arranged 10b5-1 plan, which carry limited informational value. The SVP of Logistics at MPLX sold small amounts in late August outside a plan, but the sums are not material. Net 90-day insider selling runs to roughly $11.5 million, though the bulk of that is plan-driven. Institutional ownership is steady: BlackRock holds 9.3% after adding 1.6 million shares in the latest reported period, and FMR added around 500,000 shares. No activist 13D filings are on the register.
With Q3 earnings on October 27, the next 19 days will centre on whether crack spread trends through the quarter support the margin story the bulls have been pricing in, and whether the pace of analyst target upgrades extends further above the current price or begins to stall as the stock trades through freshly raised numbers.
See the live data behind this article on ORTEX.
Open MPC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
